↓ Skip to main content

Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models

Overview of attention for article published in Acta Neuropathologica, October 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news
1 news outlet
patent
2 patents

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
95 Mendeley
Title
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
Published in
Acta Neuropathologica, October 2015
DOI 10.1007/s00401-015-1489-x
Pubmed ID
Authors

Yvonne Bouter, Jose Socrates Lopez Noguerola, Petra Tucholla, Gabriela A. N. Crespi, Michael W. Parker, Jens Wiltfang, Luke A. Miles, Thomas A. Bayer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Egypt 2 2%
India 1 1%
Unknown 92 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 17%
Student > Bachelor 13 14%
Student > Master 12 13%
Student > Ph. D. Student 11 12%
Student > Doctoral Student 6 6%
Other 13 14%
Unknown 24 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 19%
Biochemistry, Genetics and Molecular Biology 13 14%
Neuroscience 13 14%
Medicine and Dentistry 8 8%
Psychology 4 4%
Other 13 14%
Unknown 26 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2022.
All research outputs
#2,710,808
of 25,837,817 outputs
Outputs from Acta Neuropathologica
#661
of 2,606 outputs
Outputs of similar age
#36,272
of 293,439 outputs
Outputs of similar age from Acta Neuropathologica
#14
of 31 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,606 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.